Supernus Pharma - SUPN Operatsion marja

Supernus Pharma - SUPN emitenti grafik logotipi

Ishlab chiqarish va logistikani tashqi hamkorlarga autsorsing qilish natijasida asosiy operatsion marjalar kengaymoqda, 45.00 darajasi esa parametrning holatini ko'rsatadi. Savdo to'siqlari va qat'iy davlat tartibga solish choralari Supernus Pharmaceuticals (SUPN) o'sishiga to'sqinlik qilmoqda. Barqarorlikni ta'minlash uchun kompaniya epilepsiya va ADHD davolash vositalarining muvozanatli portfeliga tayanadi, bu esa unga neyromeditsina doirasidagi tor ixtisoslashgan sanoat risklarini minimallashtirish imkonini beradi.

Supernus (SUPN): Operatsion foyda normasi 04.07.2022dan 20.11.2026gacha

Supernus Pharmaceuticals (SUPN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:supernus.com, SUPN
Supernus Corp tayyor mahsulotlari

Emitentning tanlanishi foizlar va soliqlar to'lanishidan oldingi operatsion foydaning barqarorligiga asoslangan bo'lib, bu asosiy biznes jarayonlarini boshqarish samaradorligini belgilaydi. Operatsion rentabellikni tahlil qilish orqali investor Supernus Pharmaceuticals (SUPN) kompaniyasining Qelbree savdolari kengayishi va pediatrik psixiatriya segmentiga kirib borishi davridagi xavfsizlik zaxirasini baholaydi, bunda pul oqimini yaratish qobiliyati Markaziy Nerv Tizimi (CNS) dori portfelini diversifikatsiya qilish strategiyasining hayotiy ekanligini bevosita tasdiqlaydi.

Supernus Pharmaceuticals raqobatchilari

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Catalyst Pharmaceuticals Inc (CPRX) - Sotuvning operatsion marjasi|DNLI (Denali Corp) - Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi harmonybiosciences.com (HRMY)|Sotuvning operatsion marjasi BHVN|Operatsion marja Amylyx|Operatsion marja TRVI|PRAX (Praxis Corp) - Operatsion foyda normasi|Operatsion marja AVXL (anavex.com)|CBLL: Operatsion foyda bo'yicha sotuv rentabelligi|PRTA - Operatsion rentabellik|ALEC - Operatsion marja|Annexon Inc. (ANNX) - Operatsion rentabellik|Sotuvning operatsion marjasi Omeros Corp|Sotuvning operatsion marjasi NGNE|ACIU: Operatsion foyda normasi|Sotuvning operatsion marjasi VYGR (Voyager Corp)|Sotuvning operatsion marjasi Neumora NMRA|Operatsion rentabellik Scilex Holding Company, Inc. SCLX|Operatsion foyda bo'yicha marjinallik Tevogen Bio Inc.|ACOG - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Sotuvning operatsion marjasi|Cassava Sciences Inc (SAVA) - Operatsion marja|Sotuvning operatsion marjasi ASRT|Operatsion marja coyatherapeutics.com|Operatsion marja VTGN|Ovid Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Sotuvning operatsion marjasi|ATHE - Operatsion rentabellik|Operatsion faoliyat rentabelligi clene.com CLNN|PEPG: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi JUNS|RLMD (Relmada Corp) - Operatsion marja|Annovis Bio Inc (ANVS) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operatsion foyda normasi|Operatsion rentabellik Klotho Neurosciences KLTO|NRSN: Operatsion foyda bo'yicha sotuv rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi